Michael L. Alosco, PhD; Thor D. Stein, MD, PhD; Yorghos Tripodis, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1298-1308. doi:10.1001/jamaneurol.2019.2244
This cross-sectional study investigates association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who had played football and been found to have chronic traumatic encephalopathy.
Kazuo Kitagawa, MD, PhD; Yasumasa Yamamoto, MD, PhD; Hisatomi Arima, MD, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1309-1318. doi:10.1001/jamaneurol.2019.2167
This randomized clinical trial tests the hypothesis that targeting intensive blood pressure lowering of systolic and diastolic blood pressure less than 120 mm Hg and less than 80 mm Hg, respectively, reduces the rate of stroke recurrence compared with a standard blood pressure–lowering regimen.
Niklas Mattsson, MD, PhD; Sebastian Palmqvist, MD, PhD; Erik Stomrud, MD, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1319-1329. doi:10.1001/jamaneurol.2019.2214
This multicenter longitudinal cohort study of 741 participants uses in vivo β-amyloid cerebrospinal fluid and positron emission tomography findings to track progression of Alzheimer disease across 6 years of follow-up.
Lon S. Schneider, MD; Ronald G. Thomas, PhD; Suzanne Hendrix, PhD; et al.
open access
JAMA Neurol. 2019;76(11):1330-1339. doi:10.1001/jamaneurol.2019.1868
This phase 2 randomized clinical trial assesses the efficacy, safety, and tolerability of edonerpic maleate for patients with mild to moderate Alzheimer disease.
Dimitrios Kapogiannis, MD; Maja Mustapic, PhD; Michelle D. Shardell, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1340-1351. doi:10.1001/jamaneurol.2019.2462
This case-control study examines neuronal-enriched extracellular vesicles as predictors of Alzheimer disease.
Mark W. Lowerison, MSc; Colin B. Josephson, MD, MSc; Nathalie Jetté, MD, MSc; et al.
free access
JAMA Neurol. 2019;76(11):1352-1358. doi:10.1001/jamaneurol.2019.2268
This cohort study examines the association between the level of care received by Canadian patients with epilepsy and the risk of premature mortality.
Ester Cantó, PhD; Christian Barro, MD; Chao Zhao, MSc; et al.
free access
JAMA Neurol. 2019;76(11):1359-1366. doi:10.1001/jamaneurol.2019.2137
This cohort study compares changes in serum levels of neurofilament light chains with progression of disease among patients with multiple sclerosis.
Marie Ryan, MRCPI; Mark Heverin, MSc; Russell L. McLaughlin, BSc, HDip, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1367-1374. doi:10.1001/jamaneurol.2019.2044
This population-based parent-offspring heritability study examines the extent of amyotrophic lateral sclerosis heritability and assesses the association of sex with disease transmission
Douglas R. Langbehn, MD, PhD; Julie C. Stout, PhD; Sarah Gregory, PhD; et al.
free access
JAMA Neurol. 2019;76(11):1375-1385. doi:10.1001/jamaneurol.2019.2368
This study analyzes the decades-long early progression of Huntington disease and its dependence on CAG repeat length.